Coronavirus Update: AstraZeneca Makes Case For Vaxzevria Booster Against Omicron
As CEPI And SK Bio Look At 'Variant-Proof' Vaccines
Also, AstraZeneca presents more promising data for its COVID-19 antibody cocktail Evusheld and Novavax says its vaccine is able to neutralize the Omicron variant.
You may also be interested in...
Coronavirus Notebook: Vaccine Approvals In India Amid Wins And Losses For Drug Developers In China
India has issued emergency approvals for a number of new COVID-19 vaccines and extended eligible age groups for others, while developers of potential drug therapies in China have seen both gains and setbacks.
Coronavirus Update: India Approves Multiple New Vaccines
India has issued emergency approvals for a number of new vaccines and extended eligible age groups for others, while developers of potential drug therapies in China see both gains and setbacks.
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add seven new products, including Janssen-Cilag’s Rybrevant for treating patients with advanced non-small cell lung cancer.